Conversely, SPARC transfection in high‐grade isogenic breast cancer cells reduces tumor rate, and favors epithelial‐to‐mesenchymal transition and the formation of a highly immunosuppressive microenvironment composed of immune cells, such as myeloid‐derived suppressor cells.31 The gene discussed is SPARC; the disease is neoplasm.